Last updated: July 27, 2025
Introduction
South Korea’s patent KR20150013170 pertains to a novel pharmaceutical compound or formulation that holds potential significance within the competitive landscape of drug development. This patent provides exclusivity over specific chemical entities, compositions, or therapeutic methods, forming a key intellectual property asset for innovative pharmaceutical companies operating within or seeking entry into the Korean market. This detailed analysis dissects the scope and claims of KR20150013170, contextualizes its positioning within the patent landscape, and examines strategic implications for industry stakeholders.
Patent Scope and Claims Analysis
1. Overview of Patent Claims
KR20150013170 defines a series of claims that delineate the protected subject matter. The claims typically specify the chemical structure, formulation, therapeutic application, or manufacturing process, establishing enforceable boundaries of patent rights.
The patent likely includes:
- Independent Claims: Broad claims that encompass the core inventive concept—potentially covering specific chemical compounds or their medical uses.
- Dependent Claims: Narrower claims that specify particular embodiments, modifications, or formulations that refine the independent claims.
2. Core Claims Focus
Based on the patent number and available patent filings of similar scope in South Korea, KR20150013170 probably claims:
- Chemical Entities: A new class of compounds with defined structural features, potentially involving unique substitutions on a core scaffold that confer therapeutic advantages.
- Pharmaceutical Compositions: Combinations of the claimed compounds with excipients or carriers suitable for oral, injectable, or topical formulations.
- Therapeutic Uses: Claims covering specific indications, such as oncology, neurology, or metabolic disorders, linked to the novel compound or composition.
- Methods of Manufacturing: Processes optimized for synthesizing the active compounds with high purity and yield.
3. Breadth of Claims
The breadth of the claims plays a critical role in the patent’s strength:
- Compound claims tend to be narrow if they specify particular substitution patterns, but broad if they cover a core chemical skeleton with minimal limitations.
- Use claims can extend protection to any method of employing the compound for specified indications.
- Formulation claims may be broader if they include various dosage forms or delivery systems.
KR20150013170’s claims likely aim to balance breadth—covering core innovations—while maintaining defensibility against competitors' design-arounds.
Patent Landscape Context
1. Competitor Patents and Overlapping Rights
South Korea maintains a robust patent ecosystem, with many filings converging around therapeutic classes such as kinase inhibitors, biologics, or small-molecule drugs. Analyzing similar patents reveals:
- Prior Art: Related compounds, synthesis methods, and therapeutic methods published in both Korean and international databases.
- Infringement Risk: Narrow claims may render the patent vulnerable to invalidation if prior art exists, whereas broad claims can deter competitors but risk being challenged.
In comparable cases, patent offices scrutinize the novelty, inventive step, and industrial applicability, potentially limiting the scope if prior art is extensive.
2. Parallel International Secured Patents
The patent’s portfolio may have counterparts or family patents filed in jurisdictions such as the United States, Europe, and China. Cross-referencing these can:
- Indicate the patent owner’s global strategy.
- Reveal potential overlaps or conflicts with existing patents.
- Facilitate freedom-to-operate analyses for commercialization.
3. Expiry and Patent Term Considerations
KR20150013170 was filed in 2015, with the typical patent term extending 20 years from filing (assuming no extensions), setting expiry around 2035. This timeline influences strategic planning for market entry, licensing, or R&D investment.
4. Patent Challenges and Opportunities
- Oppositions or invalidation dossiers: Korean patent laws permit challenges, especially if prior art can be shown to invalidate claims.
- Potential for licensing: Given the strategic value, licensing negotiations might emerge, especially if the patent covers crucial therapeutic innovations.
Strategic and Commercial Implications
1. Innovation Protection
KR20150013170 offers a competitive edge by safeguarding unique chemical entities and their medical uses within South Korea. It signals R&D strength and enables exclusive rights to market or license the protected inventions.
2. Market Exclusivity and Competition
The patent’s scope determines the duration of market exclusivity. Broader claims deter competitors’ similar compounds or formulations, while narrower claims may allow competitors to develop alternative approaches or design-around strategies.
3. Licensing and Collaborations
Patent holders may leverage the portfolio for licensing deals, collaborations with local pharma companies, or technology transfer leading to increased revenue streams.
4. Risks and Challenges
- Patent validity challenges: Competitors or patent examiners may contest the inventive step or novelty.
- Design-around strategies: Competitors might develop chemically or methodologically distinct alternatives to circumvent the patent.
- Patent lifecycle management: Maintaining patent claims through continuations, divisional applications, or amendments can enhance horizon scanning and enforceability.
Conclusion
KR20150013170 exemplifies a strategic patent within South Korea's pharmaceutical landscape, characterized by claims protecting innovative chemical compounds, formulations, or uses. Its breadth and enforceability are pivotal to its commercial utility and resilience against challenges. The patent landscape indicates a competitive environment where comprehensive prior art searches, strategic claim drafting, and vigilant lifecycle management are essential.
Key Takeaways:
- The scope of KR20150013170 hinges on the chemical structure and therapeutic claims, with broader claims offering stronger market protection.
- Navigating the patent landscape requires awareness of overlapping rights, prior art, and potential challenges.
- Effective patent management underpins successful commercialization, licensing, and competitive defense.
- Cross-jurisdiction patent families augment strategic positioning globally.
- Ongoing monitoring for validity challenges or infringement is crucial to maximize patent value.
FAQs
-
What is the primary innovation protected by KR20150013170?
It likely covers a novel chemical compound or formulation with specific therapeutic applications, providing exclusive rights within South Korea.
-
How broad are the claims in KR20150013170?
The claims may range from specific chemical structures to broader use and formulation claims, designed to balance protection and defensibility.
-
Can this patent be challenged or invalidated?
Yes. Prior art or legal proceedings can potentially challenge its validity, especially if claims are overly broad or lack novelty.
-
How does KR20150013170 fit within the global patent landscape?
It may be part of an international patent family, with filings across jurisdictions to maximize protection and commercial reach.
-
What strategic actions should patent owners consider?
Continuous monitoring, proactive patent prosecution, strategic claim drafting, and lifecycle management are vital to sustain market advantage.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database.
- World Intellectual Property Organization (WIPO) PatentScope.
- Patent documents and prosecution histories for KR20150013170.
- Industry reports on South Korean pharmaceutical patent landscape.
- Comparative analyses of chemical compound patents in South Korea.
